Evidence map›Paper›PMID 36656308›Full record

ReviewEndocrine connections2023

Ferroptosis as a potential new therapeutic target for diabetes and its complications.

Qian Deng, Yue Zhu, Mengmeng Zhang, Aihua Fei, Jiaqi Liang, Jinjin Zheng, Qingping Zhang, Tong Cheng, Xia Ge

Open access · goldAbstract readReview
In one paragraph

Review in Endocrine connections, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Qian DengGraduate College of Anhui University of Chinese Medicine, Hefei, China.
Yue ZhuGraduate College of Anhui University of Chinese Medicine, Hefei, China.
Mengmeng ZhangGraduate College of Anhui University of Chinese Medicine, Hefei, China.
Aihua FeiDepartment of Endocrinology, The Second Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.
Jiaqi LiangGraduate College of Anhui University of Chinese Medicine, Hefei, China.
Jinjin ZhengGraduate College of Anhui University of Chinese Medicine, Hefei, China.
Qingping ZhangCollege of Acupuncture-moxibustion and Tuina, Anhui University of Chinese Medicine, Hefei, China.
Tong ChengDepartment of Geriatrics, Zhongshan Hospital, Fudan University, Shanghai, China.
Xia GeDepartment of Endocrinology, The Second Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.ORCID 0000-0002-8630-718X
Anhui University of Traditional Chinese Medicine · CNAnhui University · CNFudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes is a complex metabolic disease. In recent years, diabetes and its chronic complications have become a health hotspot of global concern. It is very important to find promising therapeutic targets and directions. Ferroptosis is a new type of programmed cell death that is different from cell necrosis, apoptosis, and autophagy. Ferroptosis is mainly characterized by iron-dependent lipid peroxidation. With the reduction of the anti-oxidative capacity of cells, the accumulated reactive lipid oxygen species will cause oxidative cell death and lead to ferroptosis at lethal levels. Recent studies have shown that ferroptosis plays an important regulatory role in the initiation and development of diabetes, as well as various complications of diabetes. In this review, we will summarize new findings related to ferroptosis and diabetic complications and propose ferroptosis as a potential target for treating diabetic complications.

Indexed as

diabetesdiabetic complicationsferroptosis

Identifiers

PMID36656308
PMCPMC9986392
OpenAlexW4317434888

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.